Clinical Trials Directory

Trials / Completed

CompletedNCT02860611

Comparison of Th1 Cytokine Levels Between Type 1 and Type 2 Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
180 (actual)
Sponsor
Istanbul Medeniyet University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Recent reports show increased prevalence of obesity in patients with type 1 diabetes (T1DP)s while some studies stated that patients with type 2 diabetes (T2DPs) have islet cell auto-antibodies. These results raise the question of a common pathway in T1DM and T2DM via an association with T helper cells. In this study investigators aimed to investigate the difference between T helper 1 (Th1) cytokines levels in T1DPs, T2DPs and healthy subjects. The study included 114 T1DPs on insulin treatment, 35 newly diagnosed T2DPs who had not used oral antidiabetics but insulin before and 31 healthy subjects (CG). Serum interferon gamma (IFN-γ), interleukin-2 (IL-2) and tumor necrosis factor alpha (TNF-α) levels were measured using ELISA method. Serum levels of those cytokines in T1DPs were compared with those in T2DPs and controls.

Conditions

Timeline

Start date
2013-02-01
Primary completion
2016-04-01
Completion
2016-06-01
First posted
2016-08-09
Last updated
2016-08-09

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02860611. Inclusion in this directory is not an endorsement.